…88%) and moderate stenosis in 6 cases (12%). No cases of severe in-stent stenosis occurred. Two-percent (n=2) overall complication rate with a pa…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 101 of 2459…similar between groups (median 47 pM vs 24 pM, p = 0.67). Among stroke patients, higher calprotectin levels were significantly associa…
…Upadacitinib is a selective Janus kinase-1 inhibitor with proven efficacy in…
… and a single case of line-related sepsis (6%) was treated with meropenem.Our study showed that short term parenteral nutrition aided nut…
…lusions Mdr2-/- mice show a limited response to BAAs (including ursodeoxycholic acid), consistent with humans who have severe loss-of-function ABCB4…
… patients who suffered from 1 or more neurodivergent condition; ARFID 31(14%) PFD 14(29%). Interestingly, 47 patients in total requir…
…to minimising bowel loss and improving neonatal outcomes. Also, cystic fibrosis remains an important co-morbid condition that must be excluded …
…arcinoma (HCC) at the very early stage (BCLC 0) is critical for curative treatment. Serum biomarkers including alpha-fetoprotein (AFP), AFP-L3, de…
…hree times daily + tegoprazan), or EBAC (esomeprazole, bismuth, amoxicillin, clarithromycin). Randomization was performed via a centralized…
…nib vs traditional drugs mechanism, IDDF2026-ABS-0129 Figure 2. Nintedanib efficacy in IBD fibrosis).Conclusions In the DSS-induced mouse …
…xidative stress (IDDF2026-ABS-0226 Figure 3. Feature importance steatosis). NLSS-fibrosis was driven by AST, age, waist circumference, an…
…mptom Inventory – Short Form; UC/CD/IBD-U: Ulcerative Colitis / Crohn’s Disease / IBD-Unclassified)Abstract IDDF2026-ABS-0235 Figure 1Abstract …